In RA patients, the seropositivity rates were as follows: ANA, 31.0%; RF, 81.9%; anti-CCP, 86.3%; anti-Ro60, 9.2%; and anti-Ro52, 10.4%. This evidence concerns the gene TRIM21 and rheumatoid arthritis.